+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Gout Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Xanthine Oxidase Inhibitors, Uricosuric Agents, Recombinant Uricase, Interleukin-1 , Colchicine, NSAIDs, Corticosteroids), By Disease Condition (Acute Gout, Chronic Gout, Tophaceous Gout, Chronic Refractory Gout), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Gout Therapeutics Market size is forecast to increase from $3.16 Billion in 2026 to $5.12 Billion in 2034 at a CAGR of 6.22% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007377
Pages: 230 Pages

Gonorrhea Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Type (Third-Generation Cephalosporins, Macrolide Antibiotics, Tetracycline Antibiotics, Fluoroquinolone Antibiotics, Aminoglycosides, Aminocyclitols), By Therapy Type (Monotherapy, Dual Therapy), By Route of Administration (Oral, Intramuscular, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Gonorrhea Therapeutics Market size is forecast to increase from $1.36 Billion in 2026 to $1.92 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007376
Pages: 222 Pages

Gonorrhea Diagnostic Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Nucleic Acid Amplification Tests , Immunochromatographic Assays, Culture Tests, Enzyme Immunoassays, Gram Stain), By Sample Type (Urine Samples, Swab Samples, Blood Samples, Lymph Fluid), By End User (Hospitals, Diagnostic Laboratories, STD Clinics, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Gonorrhea Diagnostic Market size is forecast to increase from $12.57 Billion in 2026 to $24.14 Billion in 2034 at a CAGR of 8.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007375
Pages: 214 Pages

GMP Testing Service Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Product Validation Testing , Bioanalytical Services , Packaging and Shelf-Life Testing , Environmental Monitoring & Facility Validation, Raw Material & Excipient Testing), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Manufacturers, Cosmetic & Personal-Care Companies, Food & Beverage Manufacturers) Companies, and Country Forecast, 2021 to 2034

Global GMP Testing Service Market size is forecast to increase from $1.79 Billion in 2026 to $2.73 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007374
Pages: 225 Pages

Glycomics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Chemicals, Enzymes, Kits, Equipment ), By Application (Diagnostics & Biomarker Discovery, Drug Discovery & Development, Vaccine Development, Immunology & Personalized Medicine), By End-User (Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations , Clinical & Reference Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Glycomics Market size is forecast to increase from $2.17 Billion in 2026 to $6.37 Billion in 2034 at a CAGR of 14.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007373
Pages: 214 Pages

Glycobiology Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Enzymes , Instruments , Kits , Reagents & Chemicals , Carbohydrates), By Application (Drug Discovery & Development, Disease Diagnostics , Industrial Applications, Therapeutic Applications), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories & Centers, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Glycobiology Market size is forecast to increase from $937.29 Million in 2026 to $2655 Million in 2034 at a CAGR of 13.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007372
Pages: 224 Pages

Glycated Hemoglobin (HbA1c) Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Laboratory-based Analyzers, Point-of-Care , Reagents & Consumables), By Technology (Chromatography , Immunoassays , Enzymatic Assays, Capillary Electrophoresis), By Application (Diabetes Diagnosis, Long-term Glycemic Monitoring), By End-User (Diagnostic Laboratories, Hospitals, Clinics & Physician Offices, Homecare) Companies, and Country Forecast, 2021 to 2034

Global Glycated Hemoglobin (HbA1c) Testing Market size is forecast to increase from $2.77 Billion in 2026 to $4.58 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007371
Pages: 223 Pages

Glycated Albumin Assay Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Human Glycated Albumin Assays, Animal Glycated Albumin Assays), By Testing Method (Enzymatic Methodology, High-Performance Liquid Chromatography , Immunoassays), By Application (Diagnostics , Research & Development , Veterinary Diagnostics), By End-User (Hospitals & Specialty Clinics, Diagnostic Laboratories, Research Centers & Academic Institutes) Companies, and Country Forecast, 2021 to 2034

Global Glycated Albumin Assay Market size is forecast to increase from $914.13 Million in 2026 to $1729.96 Million in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007370
Pages: 220 Pages

Glucose Biosensors Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Continuous Glucose Monitoring , Self-Monitoring Blood Glucose , Non-invasive Glucose Biosensors, Implantable Glucose Biosensors), By Technology (Electrochemical Biosensors , Optical Biosensors , Piezoelectric & Thermal Biosensors, Nanotechnology-based Biosensors), By Application (Type 1 Diabetes Management, Type 2 Diabetes Management, Gestational Diabetes), By End-User (Hospitals & Clinics, Homecare Settings, Diagnostic Centers, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Glucose Biosensors Market size is forecast to increase from $11.53 Billion in 2026 to $22.81 Billion in 2034 at a CAGR of 8.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007369
Pages: 224 Pages

GLP-1 Receptor Agonist Market Size, Share and Growth Outlook, 2026: Analysis By Action Mechanism (Short-acting GLP-1 Receptor Agonists, Long-acting GLP-1 Receptor Agonists), By Formulation Type (Monotherapy, Combination Therapy), By Route of Administration (Injectable, Oral), By End-User (Hospitals & Specialty Clinics, Homecare Settings, Diagnostic & Academic Centers) Companies, and Country Forecast, 2021 to 2034

Global GLP-1 Receptor Agonist Market size is forecast to increase from $81 Billion in 2026 to $223.08 Billion in 2034 at a CAGR of 13.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007368
Pages: 223 Pages